Assenagon Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Assenagon Asset Management's ADPT Position: Q2 2026 in Review
Assenagon Asset Management opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 23,883 shares worth $512K. The stake represents ﹤0.01% of the portfolio and ranks #1069 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in ADPT as recently as Q3 2025.
Assenagon Asset Management first reported a position in ADPT in Q1 2023 and has held it in 7 quarters since. The position peaked at $4.71M in Q3 2023. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Assenagon Asset Management held 23,883 shares of Adaptive Biotechnologies worth $512K as of Q2 2026.
- Adaptive Biotechnologies was a new Assenagon Asset Management position in Q2 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1069 holding.
- Assenagon Asset Management first reported a position in Adaptive Biotechnologies in Q1 2023 and has held it in 7 quarters since.
- Assenagon Asset Management's Adaptive Biotechnologies position peaked at $4.71M in Q3 2023.
- 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.